title: An Evaluation of the Correlation between Hepcidin Serum Levels and Disease Activity in Inflammatory Bowel Disease.
abstract: Aim. While there are many well-defined serological markers for inflammatory bowel disease (IBD), there is limited evidence that they positively affect clinical outcomes. This study aimed to evaluate the correlation between hepcidin serum levels and disease activity in IBD. Materials and Methods. Eighty-five consecutive IBD patients were enrolled in the study. Hepcidin serum levels were assessed using an enzyme-linked immunosorbent assay (ELISA) and were compared with disease activity as well as the interleukin-6 (IL-6) and C-reactive protein (CRP) levels. Results. The mean hepcidin serum levels in Crohn's disease (CD) patients in remission and in the active phase were 3837 ± 1436 and 3752 ± 1274 pg/mL, respectively (P = 0.613). The mean hepcidin serum levels in ulcerative colitis (UC) patients in remission and in the active phase were 4285 ± 8623 and 3727 ± 1176 pg/mL, respectively (P = 0.241). Correlation analysis between inflammatory markers and hepcidin serum levels indicated that there was no correlation between hepcidin levels and IL-6 (P = 0.582) or CRP (P = 0.783). Conclusion. As an acute-phase protein, hepcidin seems to have a lower efficacy than other parameters in the detection of activation in IBD.
authors: Department of Gastroenterology, Izmir Katip Çelebi University, İzmir Atatürk Eğitim ve Araştırma Hastanesi, Karabağlar, 35160 İzmir, Turkey.
authors: Zehra Betül
authors: ZB
authors: Paköz
authors: Department of Gastroenterology, Izmir Katip Çelebi University, İzmir Atatürk Eğitim ve Araştırma Hastanesi, Karabağlar, 35160 İzmir, Turkey.
authors: Cem
authors: C
authors: Çekiç
authors: Department of Gastroenterology, Izmir Katip Çelebi University, İzmir Atatürk Eğitim ve Araştırma Hastanesi, Karabağlar, 35160 İzmir, Turkey.
authors: Mahmut
authors: 0000-0002-7444-4275
authors: M
authors: Arabul
authors: Department of Gastroenterology, Izmir Katip Çelebi University, İzmir Atatürk Eğitim ve Araştırma Hastanesi, Karabağlar, 35160 İzmir, Turkey.
authors: Elif
authors: E
authors: Sarıtaş Yüksel
authors: Department of Gastroenterology, Izmir Katip Çelebi University, İzmir Atatürk Eğitim ve Araştırma Hastanesi, Karabağlar, 35160 İzmir, Turkey.
authors: Serkan
authors: S
authors: İpek
authors: Department of Gastroenterology, Izmir Katip Çelebi University, İzmir Atatürk Eğitim ve Araştırma Hastanesi, Karabağlar, 35160 İzmir, Turkey.
authors: Sezgin
authors: S
authors: Vatansever
authors: Department of Gastroenterology, Izmir Katip Çelebi University, İzmir Atatürk Eğitim ve Araştırma Hastanesi, Karabağlar, 35160 İzmir, Turkey.
authors: Belkıs
authors: B
authors: Ünsal
references: Can J Gastroenterol. 2005 Sep;19 Suppl A:5A-36A
references: 16151544
references: Nat Rev Gastroenterol Hepatol. 2010 Nov;7(11):599-610
references: 20924367
references: Inflamm Bowel Dis. 2006 Dec;12(12):1101-6
references: 17119383
references: Nat Genet. 2006 May;38(5):531-9
references: 16604073
references: Eur J Gastroenterol Hepatol. 2011 Mar;23(3):262-8
references: 21285884
references: Gastroenterology. 2007 Feb;132(2):763-86
references: 17258735
references: N Engl J Med. 1987 Dec 24;317(26):1625-9
references: 3317057
references: Eur J Gastroenterol Hepatol. 2009 Apr;21(4):425-9
references: 19262400
references: J Crohns Colitis. 2013 Sep;7(8):e286-91
references: 23219355
references: Blood. 2006 Nov 1;108(9):3204-9
references: 16835372
references: J Clin Invest. 2013 Jun;123(6):2337-43
references: 23722909
references: J Crohns Colitis. 2010 Dec;4(6):649-53
references: 21122575
references: PLoS One. 2013 Apr 23;8(4):e61050
references: 23637785
references: Hepatogastroenterology. 2013 May;60(123):595-600
references: 23665668
references: J Rheumatol. 2011 Oct;38(10):2153-9
references: 21885483
references: Inflamm Bowel Dis. 2012 Jan;18(1):112-9
references: 21351217